chr17-46010418-C-T

Variant summary

Our verdict is Pathogenic. The variant received 11 ACMG points: 12P and 1B. PS3PP5_Very_StrongBP4

The NM_001377265.1(MAPT):​c.2091+16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000729 in 1,372,328 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV001767383: Published functional studies demonstrate that this variant leads to aberrant splicing of exon 10 (PMID:23680655, 9641683)" and additional evidence is available in ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000073 ( 0 hom. )

Consequence

MAPT
NM_001377265.1 intron

Scores

2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:13O:1

Conservation

PhyloP100: 2.02

Publications

17 publications found
Variant links:
Genes affected
MAPT (HGNC:6893): (microtubule associated protein tau) This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]
MAPT Gene-Disease associations (from GenCC):
  • late-onset Parkinson disease
    Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Pick disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • semantic dementia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • supranuclear palsy, progressive, 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • progressive supranuclear palsy-parkinsonism syndrome
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 11 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV001767383: Published functional studies demonstrate that this variant leads to aberrant splicing of exon 10 (PMID: 23680655, 9641683); SCV000815082: Experimental studies have shown that this variant affects MAPT function (PMID: 9641683, 10329720, 19914360, 23680655, 26136155).; SCV002498672: RT-PCR and mini-gene assays demonstrated that the variant increases exon 10 RNA expression expected to result in a change in the ratio of tau isoforms of three amino-acid repeats to those of four amino-acid repeats (PMID: 9641683). A transgenic mouse model of the variant also recapitulates the human phenotype and demonstrates much higher levels of four-repeat tau and the adult stage (PMID: 23680655).; SCV004118409: This variant has been reported to be causative for frontotemporal dementia and results in altered splicing based on functional studies (Hutton et al. 1998. PubMed ID: 9641683; Umeda et al. 2013. PubMed ID: 23680655; Wang et al. 2010. PubMed ID: 19914360; Heutink. 2000. PubMed ID: 10767321; Sposito et al. 2015. PubMed ID: 26136155).; SCV006086681: At least one publication reports experimental evidence evaluating an impact on protein function and this variant affected the MAPT protein function (Umeda_2013).
PP5
Variant 17-46010418-C-T is Pathogenic according to our data. Variant chr17-46010418-C-T is described in ClinVar as Pathogenic. ClinVar VariationId is 98222.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52). . Strength limited to SUPPORTING due to the PP5.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001377265.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAPT
NM_001377265.1
MANE Select
c.2091+16C>T
intron
N/ANP_001364194.1A0A7I2PJZ2
MAPT
NM_001123066.4
c.1920+16C>T
intron
N/ANP_001116538.2P10636-9
MAPT
NM_016835.5
c.1866+16C>T
intron
N/ANP_058519.3P10636-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAPT
ENST00000262410.10
TSL:1 MANE Select
c.2091+16C>T
intron
N/AENSP00000262410.6A0A7I2PJZ2
MAPT
ENST00000344290.10
TSL:1
c.1801-3825C>T
intron
N/AENSP00000340820.6A0A7I2PLE3
MAPT
ENST00000351559.10
TSL:1
c.915+16C>T
intron
N/AENSP00000303214.7P10636-8

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000729
AC:
10
AN:
1372328
Hom.:
0
Cov.:
25
AF XY:
0.00000441
AC XY:
3
AN XY:
679568
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31674
American (AMR)
AF:
0.00
AC:
0
AN:
36584
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25052
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37124
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79136
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49872
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5632
European-Non Finnish (NFE)
AF:
0.00000857
AC:
9
AN:
1050116
Other (OTH)
AF:
0.0000175
AC:
1
AN:
57138
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
5
-
-
Frontotemporal dementia (5)
3
-
-
not provided (4)
2
-
-
MAPT-related disorder (2)
1
-
-
Dementia (1)
1
-
-
Memory impairment;C0234985:Mental deterioration;C0338451:Frontotemporal dementia (1)
1
-
-
Progressive supranuclear palsy-parkinsonism syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
17
DANN
Benign
0.90
PhyloP100
2.0
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs63751011; hg19: chr17-44087784; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.